We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Review · August 01, 2020

Rituximab in Patients With Pediatric MS and Other Demyelinating Disorders of the CNS

Multiple Sclerosis (Houndmills, Basingstoke, England)


Additional Info

Disclosure statements are available on the authors' profiles:

Multiple Sclerosis (Houndmills, Basingstoke, England)
Rituximab in Patients With Pediatric Multiple Sclerosis and Other Demyelinating Disorders of the CNS: Practical Considerations
Mult. Scler. 2020 Jun 19;[EPub Ahead of Print], A Ghezzi, B Banwell, A Bar-Or, T Chitnis, RC Dale, M Gorman, B Kornek, L Krupp, KM Krysko, M Nosadini, K Rostasy, J Salzer, T Schreiner, S Tenembaum, E Waubant

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading